Mereo BioPharma Group plc Sponsored ADR Stock
Mereo BioPharma Group plc Sponsored ADR Stock price
Key metrics
| Market capitalization | $342.87m |
| Enterprise Value | $279.50m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 5.62 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-47.33m |
| Free Cash Flow (TTM) Free Cash Flow | $-32.85m |
| Cash position | $69.80m |
Is Mereo BioPharma Group plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
Mereo BioPharma Group plc Sponsored ADR Stock Analysis
Analyst Opinions
9 Analysts have issued a Mereo BioPharma Group plc Sponsored ADR forecast:
Analyst Opinions
9 Analysts have issued a Mereo BioPharma Group plc Sponsored ADR forecast:
Financial data from Mereo BioPharma Group plc Sponsored ADR
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -1.09 -1.09 |
-
|
|
| EBITDA | -46 -46 |
-
|
EBIT (Operating Income) EBIT | -47 -47 |
-
|
| Net Profit | -43 -43 |
-
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Mereo BioPharma Group plc Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Mereo BioPharma Group plc Sponsored ADR Stock News
Company Profile
Mereo BioPharma Group Plc engages in the acquisition, development, and commercialization of therapeutics that aim to improve outcomes for patients with rare and specialty diseases. It focuses on the treatment of patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease. The company was founded by Denise Vera Pollard-Knight, Charles Sermon, Alastair MacKinnon, and John Richard in March 2015 and is headquartered in London, the United Kingdom.
| Head office | United Kingdom |
| CEO | Denise Scots-Knight |
| Employees | 36 |
| Founded | 2015 |
| Website | www.mereobiopharma.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
